Vineela Parvathaneni

1.8k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Vineela Parvathaneni is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Vineela Parvathaneni has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Vineela Parvathaneni's work include Inhalation and Respiratory Drug Delivery (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Vineela Parvathaneni is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Vineela Parvathaneni collaborates with scholars based in United States and Egypt. Vineela Parvathaneni's co-authors include Vivek Gupta, Nishant S. Kulkarni, Aaron Muth, Snehal K. Shukla, Nitesh K. Kunda, Dipti Kanabar, Amanda Chan, Gautam Chauhan, Bhuvaneshwar Vaidya and Xuechun Wang and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

Vineela Parvathaneni

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug repurposing: a promising tool to accelerate the drug discovery process

2019 358 citations Vineela Parvathaneni, Nishant S. Kulkarni et al. Drug Discovery Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vineela Parvathaneni United States	19	476	352	330	255	248	25	1.3k
Nishant S. Kulkarni United States	17	451 0.9×	338 1.0×	295 0.9×	211 0.8×	258 1.0×	30	1.2k
Aaron Muth United States	25	1.1k 2.4×	429 1.2×	279 0.8×	226 0.9×	230 0.9×	55	2.6k
Amitava Mitra United States	26	534 1.1×	109 0.3×	346 1.0×	744 2.9×	202 0.8×	52	1.7k
Chandraiah Godugu India	22	426 0.9×	90 0.3×	136 0.4×	140 0.5×	135 0.5×	87	1.5k
Kadria A. Elkhodairy Egypt	25	475 1.0×	267 0.8×	556 1.7×	418 1.6×	355 1.4×	42	1.6k
Congcong Lin China	19	810 1.7×	137 0.4×	493 1.5×	200 0.8×	326 1.3×	38	1.6k
Snehal K. Shukla United States	20	319 0.7×	390 1.1×	389 1.2×	322 1.3×	266 1.1×	28	1.1k
Beate Bittner Switzerland	22	398 0.8×	98 0.3×	262 0.8×	523 2.1×	170 0.7×	46	1.8k
Wael M. Elshemey Egypt	19	281 0.6×	105 0.3×	128 0.4×	47 0.2×	210 0.8×	84	1.1k
Senyi Deng China	17	424 0.9×	118 0.3×	224 0.7×	48 0.2×	165 0.7×	48	1.1k

Countries citing papers authored by Vineela Parvathaneni

Since Specialization

Citations

This map shows the geographic impact of Vineela Parvathaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vineela Parvathaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vineela Parvathaneni more than expected).

Fields of papers citing papers by Vineela Parvathaneni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vineela Parvathaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vineela Parvathaneni. The network helps show where Vineela Parvathaneni may publish in the future.

Co-authorship network of co-authors of Vineela Parvathaneni

This figure shows the co-authorship network connecting the top 25 collaborators of Vineela Parvathaneni. A scholar is included among the top collaborators of Vineela Parvathaneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vineela Parvathaneni. Vineela Parvathaneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parvathaneni, Vineela, Snehal K. Shukla, & Vivek Gupta. (2023). Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment. Pharmaceutics. 15(3). 1001–1001. 26 indexed citations

Parvathaneni, Vineela, Rameswari Chilamakuri, Nishant S. Kulkarni, et al.. (2022). Repurposing clofazimine for malignant pleural mesothelioma treatment — In-vitro assessment of efficacy and mechanism of action. Life Sciences. 306. 120843–120843. 3 indexed citations

Parvathaneni, Vineela, et al.. (2022). Inhaled Indomethacin-Loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC). Pharmaceutical Research. 39(11). 2801–2815. 25 indexed citations

Parvathaneni, Vineela, et al.. (2022). Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action. International Journal of Molecular Sciences. 23(19). 11455–11455. 8 indexed citations

Parvathaneni, Vineela, Snehal K. Shukla, Nishant S. Kulkarni, & Vivek Gupta. (2021). Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles – Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment. International Journal of Pharmaceutics. 608. 121038–121038. 20 indexed citations

Parvathaneni, Vineela. (2021). EXPLORING EFFICACY OF AN ANTI-MALARIAL NANOMEDICINE IN NON-SMALL CELL LUNG CANCER TREATMENT. 1 indexed citations

Wang, Xuechun, Vineela Parvathaneni, Snehal K. Shukla, et al.. (2020). Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. 164. 638–650. 73 indexed citations

Vaidya, Bhuvaneshwar, Nishant S. Kulkarni, Snehal K. Shukla, et al.. (2020). Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics. International Journal of Pharmaceutics. 577. 118995–118995. 62 indexed citations

Parvathaneni, Vineela, Nishant S. Kulkarni, Gautam Chauhan, et al.. (2020). Development of pharmaceutically scalable inhaled anti-cancer nanotherapy – Repurposing amodiaquine for non-small cell lung cancer (NSCLC). Materials Science and Engineering C. 115. 111139–111139. 37 indexed citations

10.

Parvathaneni, Vineela, et al.. (2020). Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC). Pharmaceutical Research. 37(7). 123–123. 23 indexed citations

11.

Parvathaneni, Vineela & Vivek Gupta. (2020). Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges. Life Sciences. 259. 118275–118275. 95 indexed citations

12.

Parvathaneni, Vineela, Rasha S. Elbatanony, Snehal K. Shukla, et al.. (2020). Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity. Journal of Molecular Liquids. 327. 114866–114866. 16 indexed citations

13.

Elbatanony, Rasha S., Vineela Parvathaneni, Nishant S. Kulkarni, et al.. (2020). Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy. Drug Delivery and Translational Research. 11(3). 927–943. 55 indexed citations

14.

Shukla, Snehal K., Amanda Chan, Vineela Parvathaneni, & Vivek Gupta. (2020). Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma – A rare thoracic cancer. International Journal of Biological Macromolecules. 160. 128–141. 36 indexed citations

15.

Shukla, Snehal K., Nishant S. Kulkarni, Dipti Kanabar, et al.. (2020). Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer. Pharmaceutical Research. 37(3). 67–67. 57 indexed citations

16.

Wang, Xuechun, Vineela Parvathaneni, Snehal K. Shukla, et al.. (2020). Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol—Applications in Non-small Cell Lung Cancer Treatment. AAPS PharmSciTech. 21(5). 183–183. 37 indexed citations

17.

Kulkarni, Nishant S., Vineela Parvathaneni, Snehal K. Shukla, et al.. (2019). Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment. European Journal of Pharmaceutical Sciences. 133. 145–159. 51 indexed citations

18.

Parvathaneni, Vineela, et al.. (2019). Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC). A3956–A3956. 1 indexed citations

19.

Parvathaneni, Vineela, Nishant S. Kulkarni, Aaron Muth, & Vivek Gupta. (2019). Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discovery Today. 24(10). 2076–2085. 358 indexed citations breakdown →

20.

Vaidya, Bhuvaneshwar, Vineela Parvathaneni, Nishant S. Kulkarni, et al.. (2018). Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. 122. 338–347. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact